| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance-Related Disorders | 38 | 2022 | 305 | 7.910 |
Why?
|
| Alcoholism | 22 | 2023 | 235 | 6.490 |
Why?
|
| Crisis Intervention | 5 | 2023 | 8 | 3.030 |
Why?
|
| Primary Health Care | 20 | 2023 | 693 | 2.820 |
Why?
|
| Alcohol Drinking | 12 | 2023 | 298 | 2.410 |
Why?
|
| Referral and Consultation | 10 | 2022 | 147 | 1.810 |
Why?
|
| Humans | 91 | 2023 | 16832 | 1.780 |
Why?
|
| Telemedicine | 3 | 2022 | 190 | 1.700 |
Why?
|
| Adolescent Health Services | 4 | 2021 | 36 | 1.600 |
Why?
|
| Depression | 13 | 2022 | 479 | 1.480 |
Why?
|
| Male | 65 | 2022 | 9556 | 1.350 |
Why?
|
| Adult | 37 | 2023 | 7255 | 1.300 |
Why?
|
| Anxiety | 5 | 2020 | 154 | 1.280 |
Why?
|
| Behavior, Addictive | 2 | 2022 | 9 | 1.270 |
Why?
|
| Mass Screening | 9 | 2022 | 670 | 1.260 |
Why?
|
| Adolescent | 38 | 2022 | 3464 | 1.250 |
Why?
|
| Motivational Interviewing | 6 | 2022 | 29 | 1.230 |
Why?
|
| Delivery of Health Care, Integrated | 8 | 2022 | 515 | 1.230 |
Why?
|
| Female | 66 | 2022 | 12193 | 1.220 |
Why?
|
| Atrial Fibrillation | 7 | 2009 | 173 | 1.220 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 49 | 1.200 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 56 | 1.200 |
Why?
|
| Mental Disorders | 10 | 2020 | 248 | 1.140 |
Why?
|
| Anxiety Disorders | 3 | 2020 | 96 | 1.070 |
Why?
|
| Mental Health Services | 6 | 2021 | 132 | 1.070 |
Why?
|
| Substance Abuse Treatment Centers | 8 | 2016 | 35 | 1.000 |
Why?
|
| Stroke | 6 | 2009 | 297 | 0.930 |
Why?
|
| Cannabis | 3 | 2022 | 79 | 0.910 |
Why?
|
| Hypertension | 2 | 2023 | 475 | 0.900 |
Why?
|
| Health Services Accessibility | 4 | 2020 | 262 | 0.890 |
Why?
|
| Pandemics | 4 | 2022 | 289 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 677 | 0.850 |
Why?
|
| Comorbidity | 14 | 2021 | 516 | 0.830 |
Why?
|
| Middle Aged | 36 | 2021 | 7515 | 0.820 |
Why?
|
| Cardiovascular Diseases | 7 | 2019 | 520 | 0.780 |
Why?
|
| Anticoagulants | 6 | 2009 | 127 | 0.760 |
Why?
|
| Aged | 26 | 2021 | 5901 | 0.720 |
Why?
|
| Kidney Diseases | 5 | 2011 | 51 | 0.690 |
Why?
|
| Chronic Pain | 2 | 2020 | 125 | 0.690 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 374 | 0.660 |
Why?
|
| Depressive Disorder | 4 | 2018 | 177 | 0.660 |
Why?
|
| Anti-Anxiety Agents | 1 | 2019 | 5 | 0.610 |
Why?
|
| Health Care Costs | 3 | 2019 | 192 | 0.610 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 35 | 0.610 |
Why?
|
| Benzodiazepines | 1 | 2019 | 27 | 0.600 |
Why?
|
| Treatment Outcome | 18 | 2021 | 1098 | 0.600 |
Why?
|
| California | 14 | 2021 | 2244 | 0.600 |
Why?
|
| Mental Health | 3 | 2012 | 161 | 0.580 |
Why?
|
| Aging | 1 | 2020 | 146 | 0.580 |
Why?
|
| Managed Care Programs | 6 | 2006 | 275 | 0.570 |
Why?
|
| Chronic Disease | 7 | 2016 | 382 | 0.560 |
Why?
|
| HIV Infections | 6 | 2021 | 708 | 0.550 |
Why?
|
| Psychology, Clinical | 1 | 2017 | 1 | 0.530 |
Why?
|
| Young Adult | 12 | 2022 | 2456 | 0.530 |
Why?
|
| Risk Factors | 17 | 2020 | 3108 | 0.520 |
Why?
|
| Child | 13 | 2022 | 2433 | 0.510 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 64 | 0.460 |
Why?
|
| Smoking | 5 | 2021 | 373 | 0.460 |
Why?
|
| Kidney Failure, Chronic | 2 | 2016 | 144 | 0.450 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2019 | 155 | 0.450 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 290 | 0.440 |
Why?
|
| Health Status | 2 | 2016 | 256 | 0.430 |
Why?
|
| Heart Failure | 4 | 2008 | 403 | 0.430 |
Why?
|
| Health Personnel | 1 | 2015 | 132 | 0.420 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 189 | 0.410 |
Why?
|
| Marijuana Smoking | 4 | 2018 | 40 | 0.390 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 1058 | 0.380 |
Why?
|
| Patient Compliance | 4 | 2013 | 262 | 0.370 |
Why?
|
| United States | 13 | 2021 | 3858 | 0.370 |
Why?
|
| Hospitalization | 4 | 2019 | 816 | 0.360 |
Why?
|
| Prevalence | 6 | 2021 | 785 | 0.350 |
Why?
|
| Glomerular Filtration Rate | 6 | 2016 | 157 | 0.340 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 5 | 2021 | 17 | 0.330 |
Why?
|
| Adolescent Behavior | 4 | 2017 | 118 | 0.330 |
Why?
|
| Vitamin K | 2 | 2008 | 14 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2022 | 317 | 0.330 |
Why?
|
| Analgesics, Opioid | 3 | 2020 | 239 | 0.320 |
Why?
|
| Continuity of Patient Care | 2 | 2021 | 94 | 0.310 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 1233 | 0.310 |
Why?
|
| Warfarin | 4 | 2009 | 72 | 0.290 |
Why?
|
| Aged, 80 and over | 8 | 2019 | 1887 | 0.290 |
Why?
|
| Health Maintenance Organizations | 3 | 2006 | 358 | 0.290 |
Why?
|
| Patient Participation | 2 | 2022 | 120 | 0.280 |
Why?
|
| Feasibility Studies | 2 | 2021 | 108 | 0.280 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 2008 | 42 | 0.270 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2018 | 353 | 0.270 |
Why?
|
| Sex Factors | 6 | 2021 | 560 | 0.270 |
Why?
|
| Odds Ratio | 5 | 2022 | 569 | 0.270 |
Why?
|
| Oligosaccharides | 1 | 2008 | 2 | 0.270 |
Why?
|
| Electronic Health Records | 3 | 2020 | 702 | 0.270 |
Why?
|
| Self-Help Groups | 3 | 2013 | 22 | 0.260 |
Why?
|
| Myocardial Infarction | 2 | 2011 | 215 | 0.250 |
Why?
|
| Fibrinolytic Agents | 2 | 2009 | 45 | 0.240 |
Why?
|
| Cohort Studies | 7 | 2020 | 2396 | 0.240 |
Why?
|
| Private Sector | 1 | 2006 | 11 | 0.240 |
Why?
|
| Hemoglobins | 1 | 2006 | 38 | 0.240 |
Why?
|
| Anemia | 1 | 2006 | 34 | 0.230 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2021 | 100 | 0.230 |
Why?
|
| Models, Organizational | 1 | 2006 | 50 | 0.230 |
Why?
|
| San Francisco | 4 | 2016 | 54 | 0.220 |
Why?
|
| Age Factors | 4 | 2021 | 814 | 0.220 |
Why?
|
| Retrospective Studies | 4 | 2019 | 2463 | 0.220 |
Why?
|
| Temperance | 3 | 2016 | 10 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 160 | 0.210 |
Why?
|
| Cause of Death | 3 | 2016 | 171 | 0.200 |
Why?
|
| Alcohol-Related Disorders | 3 | 2021 | 36 | 0.190 |
Why?
|
| Factor V | 1 | 2003 | 4 | 0.190 |
Why?
|
| Risk-Taking | 3 | 2016 | 92 | 0.190 |
Why?
|
| Thromboembolism | 3 | 2009 | 32 | 0.190 |
Why?
|
| Self-Injurious Behavior | 2 | 2022 | 45 | 0.190 |
Why?
|
| Pediatrics | 2 | 2015 | 147 | 0.190 |
Why?
|
| Surveys and Questionnaires | 7 | 2020 | 1204 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 229 | 0.180 |
Why?
|
| Probability | 1 | 2022 | 66 | 0.180 |
Why?
|
| Risk Assessment | 4 | 2020 | 1047 | 0.180 |
Why?
|
| Pharmacists | 1 | 2022 | 53 | 0.180 |
Why?
|
| Diabetes Mellitus | 3 | 2019 | 445 | 0.180 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2022 | 63 | 0.180 |
Why?
|
| International Classification of Diseases | 1 | 2022 | 84 | 0.180 |
Why?
|
| Outpatients | 2 | 2019 | 99 | 0.180 |
Why?
|
| Central Nervous System Agents | 1 | 2021 | 5 | 0.180 |
Why?
|
| Angina, Stable | 1 | 2011 | 2 | 0.180 |
Why?
|
| Machine Learning | 1 | 2022 | 60 | 0.180 |
Why?
|
| Telephone | 1 | 2022 | 157 | 0.170 |
Why?
|
| Recurrence | 2 | 2016 | 149 | 0.170 |
Why?
|
| Mortality | 2 | 2016 | 116 | 0.170 |
Why?
|
| Suicidal Ideation | 2 | 2022 | 98 | 0.170 |
Why?
|
| Social Stigma | 1 | 2021 | 16 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 8 | 0.160 |
Why?
|
| Vaping | 1 | 2021 | 18 | 0.160 |
Why?
|
| Coronary Disease | 1 | 2011 | 125 | 0.160 |
Why?
|
| Tobacco Smoking | 1 | 2021 | 16 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 35 | 0.160 |
Why?
|
| Case-Control Studies | 5 | 2013 | 995 | 0.160 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 137 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2017 | 1186 | 0.160 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2021 | 27 | 0.160 |
Why?
|
| Counseling | 1 | 2022 | 170 | 0.160 |
Why?
|
| Gender Identity | 1 | 2020 | 33 | 0.160 |
Why?
|
| Workload | 1 | 2020 | 26 | 0.160 |
Why?
|
| Respiratory System | 1 | 2020 | 2 | 0.160 |
Why?
|
| Activities of Daily Living | 2 | 2018 | 71 | 0.160 |
Why?
|
| Health Services for the Aged | 1 | 2020 | 14 | 0.160 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 174 | 0.160 |
Why?
|
| Transgender Persons | 1 | 2020 | 44 | 0.160 |
Why?
|
| Pilot Projects | 1 | 2021 | 210 | 0.160 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2020 | 28 | 0.150 |
Why?
|
| Lorazepam | 1 | 2019 | 2 | 0.150 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2020 | 48 | 0.150 |
Why?
|
| Health Services Needs and Demand | 2 | 2010 | 84 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 36 | 0.150 |
Why?
|
| Peer Group | 3 | 2012 | 50 | 0.150 |
Why?
|
| Prescription Drugs | 1 | 2020 | 29 | 0.150 |
Why?
|
| Self-Management | 1 | 2019 | 25 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2016 | 410 | 0.150 |
Why?
|
| Risk | 4 | 2010 | 453 | 0.150 |
Why?
|
| Hospital Costs | 1 | 2019 | 37 | 0.150 |
Why?
|
| Health Resources | 1 | 2019 | 35 | 0.150 |
Why?
|
| Suicide | 1 | 2020 | 114 | 0.150 |
Why?
|
| Depressive Disorder, Major | 1 | 2020 | 95 | 0.140 |
Why?
|
| Smoking Cessation | 1 | 2020 | 140 | 0.140 |
Why?
|
| Social Support | 2 | 2012 | 195 | 0.140 |
Why?
|
| Text Messaging | 1 | 2019 | 39 | 0.140 |
Why?
|
| Longitudinal Studies | 5 | 2021 | 653 | 0.140 |
Why?
|
| Data Collection | 3 | 2010 | 223 | 0.140 |
Why?
|
| Logistic Models | 5 | 2021 | 796 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2017 | 278 | 0.140 |
Why?
|
| Medical Marijuana | 1 | 2018 | 21 | 0.140 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 103 | 0.130 |
Why?
|
| Outcome and Process Assessment (Health Care) | 2 | 2016 | 85 | 0.130 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 185 | 0.130 |
Why?
|
| Carbazoles | 1 | 2007 | 2 | 0.130 |
Why?
|
| Tartrates | 1 | 2007 | 2 | 0.130 |
Why?
|
| Propanolamines | 1 | 2007 | 3 | 0.130 |
Why?
|
| Pediatricians | 1 | 2017 | 14 | 0.130 |
Why?
|
| Metoprolol | 1 | 2007 | 6 | 0.130 |
Why?
|
| Atenolol | 1 | 2007 | 6 | 0.130 |
Why?
|
| Marijuana Abuse | 1 | 2017 | 33 | 0.130 |
Why?
|
| Marijuana Use | 1 | 2017 | 32 | 0.130 |
Why?
|
| Family | 3 | 2012 | 99 | 0.120 |
Why?
|
| Income | 1 | 2017 | 81 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 14 | 0.120 |
Why?
|
| Intersectoral Collaboration | 1 | 2016 | 11 | 0.120 |
Why?
|
| Social Class | 1 | 2017 | 106 | 0.120 |
Why?
|
| Angina Pectoris | 1 | 2006 | 6 | 0.120 |
Why?
|
| Inservice Training | 1 | 2015 | 11 | 0.120 |
Why?
|
| Hemorrhage | 2 | 2008 | 62 | 0.120 |
Why?
|
| Psychometrics | 4 | 2020 | 114 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 393 | 0.110 |
Why?
|
| Health Services | 1 | 2016 | 100 | 0.110 |
Why?
|
| Leadership | 1 | 2015 | 34 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2007 | 161 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 80 | 0.110 |
Why?
|
| Coronary Artery Disease | 1 | 2006 | 79 | 0.110 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2016 | 199 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2017 | 235 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 571 | 0.110 |
Why?
|
| Physicians | 1 | 2015 | 114 | 0.110 |
Why?
|
| Creatinine | 3 | 2009 | 67 | 0.100 |
Why?
|
| Obesity | 1 | 2020 | 811 | 0.100 |
Why?
|
| Interpersonal Relations | 2 | 2012 | 38 | 0.100 |
Why?
|
| Incidence | 4 | 2019 | 1229 | 0.100 |
Why?
|
| Proportional Hazards Models | 3 | 2007 | 657 | 0.100 |
Why?
|
| Ambulatory Care | 2 | 2012 | 205 | 0.100 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 41 | 0.090 |
Why?
|
| Case Management | 2 | 2010 | 27 | 0.090 |
Why?
|
| School Health Services | 1 | 2012 | 39 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 325 | 0.090 |
Why?
|
| Friends | 1 | 2012 | 9 | 0.090 |
Why?
|
| Social Environment | 3 | 2012 | 77 | 0.090 |
Why?
|
| Renal Dialysis | 2 | 2006 | 57 | 0.090 |
Why?
|
| Health Policy | 1 | 2012 | 101 | 0.090 |
Why?
|
| Pain | 1 | 2012 | 65 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2012 | 33 | 0.090 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 3 | 0.080 |
Why?
|
| Patient Care | 1 | 2011 | 31 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2012 | 136 | 0.080 |
Why?
|
| Reimbursement Mechanisms | 1 | 2010 | 15 | 0.080 |
Why?
|
| Health Care Reform | 1 | 2010 | 19 | 0.080 |
Why?
|
| Parents | 2 | 2020 | 298 | 0.080 |
Why?
|
| Financing, Government | 1 | 2010 | 23 | 0.080 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 58 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2010 | 45 | 0.080 |
Why?
|
| Evidence-Based Practice | 1 | 2010 | 48 | 0.080 |
Why?
|
| Cooperative Behavior | 2 | 2008 | 84 | 0.070 |
Why?
|
| Religion | 1 | 2009 | 14 | 0.070 |
Why?
|
| Proteinuria | 1 | 2009 | 24 | 0.070 |
Why?
|
| Prognosis | 2 | 2010 | 568 | 0.070 |
Why?
|
| Tobacco Use Cessation | 1 | 2008 | 16 | 0.070 |
Why?
|
| Research Design | 1 | 2010 | 319 | 0.070 |
Why?
|
| Self Care | 1 | 2008 | 139 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2008 | 60 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 989 | 0.060 |
Why?
|
| Systole | 1 | 2006 | 21 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2006 | 34 | 0.060 |
Why?
|
| Organizational Case Studies | 1 | 2006 | 20 | 0.060 |
Why?
|
| Universities | 1 | 2006 | 9 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 54 | 0.060 |
Why?
|
| Antifibrinolytic Agents | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 5 | 0.060 |
Why?
|
| Aspirin | 1 | 2005 | 61 | 0.060 |
Why?
|
| Self Report | 2 | 2020 | 248 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 157 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2012 | 207 | 0.050 |
Why?
|
| Family Relations | 1 | 2004 | 15 | 0.050 |
Why?
|
| Ethnic Groups | 1 | 2006 | 418 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2003 | 33 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2003 | 36 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2003 | 98 | 0.050 |
Why?
|
| Neoplasms | 1 | 2006 | 447 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 2 | 2012 | 67 | 0.040 |
Why?
|
| Survival Rate | 2 | 2008 | 247 | 0.040 |
Why?
|
| Nicotine | 1 | 2021 | 25 | 0.040 |
Why?
|
| Wounds and Injuries | 2 | 1997 | 40 | 0.040 |
Why?
|
| Time | 2 | 2010 | 16 | 0.040 |
Why?
|
| Length of Stay | 2 | 2012 | 169 | 0.040 |
Why?
|
| Breast Feeding | 1 | 2021 | 112 | 0.040 |
Why?
|
| Lipids | 1 | 2019 | 66 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2021 | 123 | 0.040 |
Why?
|
| South Africa | 2 | 2010 | 12 | 0.040 |
Why?
|
| Buprenorphine | 1 | 2020 | 50 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 346 | 0.040 |
Why?
|
| Demography | 2 | 2012 | 89 | 0.040 |
Why?
|
| Community Health Services | 2 | 2010 | 68 | 0.040 |
Why?
|
| Drug Overdose | 1 | 2020 | 62 | 0.040 |
Why?
|
| Medicare | 1 | 2020 | 188 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2021 | 828 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2017 | 20 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 56 | 0.030 |
Why?
|
| Aluminum | 1 | 2007 | 15 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 94 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 104 | 0.030 |
Why?
|
| Wounds, Gunshot | 1 | 1997 | 18 | 0.030 |
Why?
|
| Alcoholic Intoxication | 1 | 1996 | 5 | 0.030 |
Why?
|
| Bicycling | 1 | 1996 | 5 | 0.030 |
Why?
|
| Accidents, Traffic | 1 | 1996 | 15 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2006 | 84 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2009 | 261 | 0.030 |
Why?
|
| Suicide, Attempted | 1 | 1997 | 92 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2006 | 27 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 64 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1555 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 113 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2004 | 120 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2004 | 191 | 0.030 |
Why?
|
| Hospitals, Voluntary | 1 | 2012 | 3 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 54 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 129 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 58 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2006 | 925 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 76 | 0.020 |
Why?
|
| Geriatric Assessment | 1 | 2011 | 41 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 1430 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 489 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 88 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2010 | 112 | 0.020 |
Why?
|
| Biomarkers | 1 | 2010 | 284 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 252 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 175 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2009 | 44 | 0.020 |
Why?
|
| Asthma | 1 | 2012 | 375 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2008 | 19 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2008 | 29 | 0.020 |
Why?
|
| Research | 1 | 2008 | 53 | 0.020 |
Why?
|
| Motivation | 1 | 2008 | 103 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2008 | 294 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1212 | 0.020 |
Why?
|
| Quality of Health Care | 1 | 2008 | 249 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2006 | 16 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2006 | 33 | 0.010 |
Why?
|
| Child Rearing | 1 | 2004 | 3 | 0.010 |
Why?
|
| Conflict (Psychology) | 1 | 2004 | 4 | 0.010 |
Why?
|
| Conduct Disorder | 1 | 2004 | 4 | 0.010 |
Why?
|
| Family Health | 1 | 2004 | 40 | 0.010 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 54 | 0.010 |
Why?
|
| Social Work | 1 | 2003 | 15 | 0.010 |
Why?
|
| Health Services Research | 1 | 2003 | 180 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2003 | 121 | 0.010 |
Why?
|
| Sex Distribution | 1 | 1997 | 164 | 0.010 |
Why?
|
| Head Protective Devices | 1 | 1996 | 4 | 0.010 |
Why?
|
| Maryland | 1 | 1996 | 17 | 0.010 |
Why?
|
| Firearms | 1 | 1997 | 32 | 0.010 |
Why?
|
| Age Distribution | 1 | 1997 | 221 | 0.010 |
Why?
|
| Ethanol | 1 | 1996 | 19 | 0.010 |
Why?
|
| Registries | 1 | 1997 | 449 | 0.010 |
Why?
|